-transparent.png){kind=logo}
In order to ascertain the platelet sensitivity to prostacyclin (PGI2) in patients with diabetes mellitus, we determined the percentage inhibition of platelet aggregation and platelet ATP secretion following PGI2 addition in an in vitro system. The percentage inhibition of platelet aggregation caused by PGI2 in final concentration of 1.25, 2.5, or 5.0 ng/ml was significantly lower in diabetics than in healthy controls. That of platelet ATP secretion by 1.25 or 2.5 ng/ml of PGI2 was also significantly lower in diabetics. These data suggested that in patients with diabetes mellitus, the decreased sensitivity of platelets to PGI2 will bring about hypercoagulability and may become one of the risk factors of diabetic microangiopathy in cooperation with lowered vascular PGI2 generation.
T Akai, and
K Naka, and
K Okuda, and
T Takemura, and
S Fujii
August 1988,
European journal of clinical investigation,
T Akai, and
K Naka, and
K Okuda, and
T Takemura, and
S Fujii
April 1985,
Annals of the Academy of Medicine, Singapore,
T Akai, and
K Naka, and
K Okuda, and
T Takemura, and
S Fujii
February 1981,
Prostaglandins and medicine,
T Akai, and
K Naka, and
K Okuda, and
T Takemura, and
S Fujii
July 1981,
Wiener klinische Wochenschrift,
T Akai, and
K Naka, and
K Okuda, and
T Takemura, and
S Fujii
January 1979,
Bibliotheca anatomica,
T Akai, and
K Naka, and
K Okuda, and
T Takemura, and
S Fujii
January 1984,
Problemy endokrinologii,
T Akai, and
K Naka, and
K Okuda, and
T Takemura, and
S Fujii
January 1979,
VASA. Zeitschrift fur Gefasskrankheiten,
T Akai, and
K Naka, and
K Okuda, and
T Takemura, and
S Fujii
January 1988,
Voprosy meditsinskoi khimii,
T Akai, and
K Naka, and
K Okuda, and
T Takemura, and
S Fujii
January 1981,
Prostaglandins,
T Akai, and
K Naka, and
K Okuda, and
T Takemura, and
S Fujii
February 2005,
Journal of molecular medicine (Berlin, Germany),
